US Stock Market Move | Boston Scientific Corporation (BSX.US) acquires medical device manufacturer Penumbra (PEN.US) at a premium, causing its stock price to rise over 12% in pre-market trading.

22:09 15/01/2026

Boston Scientific agrees to acquire medical device manufacturer Penumbra for over $14 billion.

On Thursday, Boston Scientific Corporation (BSX.US) agreed to acquire medical device manufacturer Penumbra (PEN.US) for a valuation of over $14 billion. Penumbra's stock price surged over 12% in pre-market trading to $352.6. Boston Scientific Corporation will acquire Penumbra in a cash and stock deal, with a price of $374 per share, representing a premium of approximately 19% over Penumbra's closing price on Wednesday. Penumbra shareholders can choose to receive $374 in cash per share, or exchange for 3.8721 shares of Boston Scientific Corporation common stock. The equity value of the transaction is estimated to be around $14.6 billion and is expected to be completed within this year.

HI SUN TECH (00818) issued 150 million yuan of asset-backed securities.

AV CONCEPT HOLD (00595) purchased 1 million shares for $380,800 on March 12th.

Power Construction Corporation of China, Ltd (POWERCHINA) signed a joint venture contract worth 13.962 billion yuan for a photovoltaic energy storage project EPC contract.

HI SUN TECH (00818) issued 150 million yuan of asset-backed securities.

AV CONCEPT HOLD (00595) purchased 1 million shares for $380,800 on March 12th.

Power Construction Corporation of China, Ltd (POWERCHINA) signed a joint venture contract worth 13.962 billion yuan for a photovoltaic energy storage project EPC contract.